Constitutive activity of transient receptor potential vanilloid type 1 triggers spontaneous firing in nerve growth factor-treated dorsal root ganglion neurons of rats
IBRO Reports · 2018-12 · 5 · 33-42
DOI: 10.1016/j.ibror.2018.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift IBRO Reports, 2018-12. Verfasst von Naoki Kitamura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Physiology, Joint Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, 4-101, Koyama-cho Minami, T…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: KAKENHI.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Veterinary Physiology, Joint Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, 4-101, Koyama-cho Minami, Tottori 680-8553, Japan.
Förderung
- KAKENHI
Zitieren
APA
Kitamura, N., Nagami, E., Matsushita, Y., Kayano, T., & Shibuya, I. (2018). Constitutive activity of transient receptor potential vanilloid type 1 triggers spontaneous firing in nerve growth factor-treated dorsal root ganglion neurons of rats. IBRO Reports, 5, 33-42. https://doi.org/10.1016/j.ibror.2018.08.002
Vancouver
Kitamura N, Nagami E, Matsushita Y, Kayano T, Shibuya I. Constitutive activity of transient receptor potential vanilloid type 1 triggers spontaneous firing in nerve growth factor-treated dorsal root ganglion neurons of rats. IBRO Reports. 2018;5:33-42. doi:10.1016/j.ibror.2018.08.002
BibTeX
@article{Kitamura2018,
author = {Kitamura, Naoki and Nagami, Erika and Matsushita, Yumi and Kayano, Tomohiko and Shibuya, Izumi},
title = {Constitutive activity of transient receptor potential vanilloid type 1 triggers spontaneous firing in nerve growth factor-treated dorsal root ganglion neurons of rats},
journal = {IBRO Reports},
year = {2018},
volume = {5},
pages = {33--42},
doi = {10.1016/j.ibror.2018.08.002}
}
EUVIMED